BEUDAMED
    13 results · 28ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    Single Use Grasping Forceps FG-214P, Single Use Grasping Forceps FG-220P, Single Use Grasping Forceps FG-226C, Single Use Grasping Forceps FG-232L, Single Use Grasping Forceps FG-804L

    FDA 510(k)
    FDA Class 2 ·Ear, Nose, Throat

    CoRoent

    FDA UDI
    Nuvasive, Inc.·00887517628220·CoRoent Ant TLIF Ti, 10x10x34mm 12°

    INBONE

    FDA UDI
    WRIGHT MEDICAL TECHNOLOGY, INC.·00840420196347·Removal Screw Handle

    Saw Blade

    FDA UDI
    Treace Medical Concepts, Inc.·00810111224536·FeatherRasp - L

    METZENBAUM SCISSORS

    FDA UDI
    SONTEC INSTRUMENTS, INC.·00192896054813·METZENBAUM SCISSORS CURVED BLADES POWER CUT GOLD

    UNIVERSAL NEURO 3

    FDA UDI
    Stryker Leibinger GmbH & Co. KG·07613327600971·Translabyrinthine plate small

    UNIFIL FLOW

    FDA 510(k)
    FDA Class 2 ·Dental

    CO2 Laser System

    FDA 510(k)
    FDA Class 2 ·General, Plastic Surgery

    ANIMAS INSULIN CARTRIDGE

    FDA Adverse Event
    Injury ·ANIMAS CORPORATION·Product code LZG·December 27, 2016

    ANEURX

    FDA Adverse Event
    Malfunction ·MEDTRONIC IRELAND·Product code MIH·October 24, 2014

    COLLEAGUE PRE P1.7

    FDA Adverse Event
    Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·August 11, 2011

    CYLOS DR-T

    FDA Adverse Event
    Injury ·BIOTRONIK SE & CO. KG·Product code DXY·July 1, 2013

    Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

    FDA Enforcement
    Class II ·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020